SCIORTINO, Giuseppe
 Distribuzione geografica
Continente #
NA - Nord America 1.227
AS - Asia 674
SA - Sud America 507
EU - Europa 229
AF - Africa 39
Totale 2.676
Nazione #
US - Stati Uniti d'America 1.176
BR - Brasile 456
SG - Singapore 314
CN - Cina 126
HK - Hong Kong 67
FI - Finlandia 57
VN - Vietnam 46
UA - Ucraina 42
DE - Germania 30
IT - Italia 27
TR - Turchia 23
AR - Argentina 22
MX - Messico 21
CA - Canada 19
IQ - Iraq 17
ZA - Sudafrica 16
IN - India 14
PL - Polonia 14
BD - Bangladesh 12
GB - Regno Unito 11
SE - Svezia 11
EC - Ecuador 9
JP - Giappone 9
KR - Corea 9
NL - Olanda 9
ID - Indonesia 7
JO - Giordania 7
MA - Marocco 7
ES - Italia 6
UZ - Uzbekistan 6
VE - Venezuela 6
CO - Colombia 5
RU - Federazione Russa 5
HN - Honduras 4
AE - Emirati Arabi Uniti 3
AT - Austria 3
BE - Belgio 3
CL - Cile 3
FR - Francia 3
KE - Kenya 3
SA - Arabia Saudita 3
AO - Angola 2
AZ - Azerbaigian 2
DO - Repubblica Dominicana 2
IE - Irlanda 2
JM - Giamaica 2
NP - Nepal 2
PA - Panama 2
PE - Perù 2
PK - Pakistan 2
PY - Paraguay 2
SN - Senegal 2
TN - Tunisia 2
AL - Albania 1
CG - Congo 1
DZ - Algeria 1
EG - Egitto 1
GA - Gabon 1
GE - Georgia 1
GF - Guiana Francese 1
HU - Ungheria 1
LT - Lituania 1
MD - Moldavia 1
MN - Mongolia 1
NA - Namibia 1
OM - Oman 1
PH - Filippine 1
QA - Qatar 1
RO - Romania 1
RS - Serbia 1
TT - Trinidad e Tobago 1
TZ - Tanzania 1
UY - Uruguay 1
YT - Mayotte 1
Totale 2.676
Città #
Dallas 453
Chandler 209
Singapore 168
Hong Kong 67
Ashburn 59
Beijing 52
Princeton 38
Helsinki 34
São Paulo 29
Shanghai 22
Los Angeles 18
New York 16
Ho Chi Minh City 15
Mountain View 15
Wilmington 14
Falkenstein 13
Hanoi 13
Rio de Janeiro 13
Santa Clara 13
Council Bluffs 12
The Dalles 12
Warsaw 12
Belo Horizonte 10
Columbus 10
Brasília 9
Espoo 9
Seoul 9
Tokyo 9
Amman 7
Denver 7
Johannesburg 7
Lappeenranta 7
Orem 7
Querétaro 7
Salvador 7
Toronto 7
Atlanta 6
Jakarta 6
Montreal 6
Porto Alegre 6
San Francisco 6
San Jose 6
Turku 6
Baghdad 5
Boardman 5
Campinas 5
Cape Town 5
Curitiba 5
Phoenix 5
Quartucciu 5
Recife 5
Santo André 5
Stockholm 5
Tashkent 5
Amsterdam 4
Ankara 4
Diadema 4
Florianópolis 4
Guarulhos 4
Istanbul 4
Maringá 4
Mexico City 4
Munich 4
Poplar 4
Sorocaba 4
Sumaré 4
Ann Arbor 3
Barbianello 3
Brussels 3
Campo Grande 3
Chicago 3
Erbil 3
Frankfurt am Main 3
Guayaquil 3
Haiphong 3
Jacksonville 3
Kilis 3
London 3
Manaus 3
Marília 3
Mauá 3
Montes Claros 3
Nairobi 3
Nanchang 3
Nuremberg 3
Osasco 3
Ottawa 3
Quito 3
Ribeirão Preto 3
Riyadh 3
Rome 3
São Bernardo do Campo 3
São Gonçalo 3
São José dos Campos 3
Volta Redonda 3
Águas Lindas de Goiás 3
Americana 2
Angra dos Reis 2
Antakya 2
Aracaju 2
Totale 1.652
Nome #
Covalent and non-covalent binding in vanadium–protein adducts 119
Chemistry of mixed-ligand oxidovanadium(IV) complexes of aroylhydrazones incorporating quinoline derivatives: Study of solution behavior, theoretical evaluation and protein/DNA interaction 118
DFT Protocol for EPR Prediction of Paramagnetic Cu(II) Complexes and Application to Protein Binding Sites 115
Biospeciation of Potential Vanadium Drugs of Acetylacetonate in the Presence of Proteins 110
ESI-MS Study of the Interaction of Potential Oxidovanadium(IV) Drugs and Amavadin with Model Proteins 108
Binding of potential antitumor Casiopeínas® to small proteins 106
Rationalizing the Decavanadate(V) and Oxidovanadium(IV) Binding to G-Actin and the Competition with Decaniobate(V) and ATP 105
Effect of secondary interactions, steric hindrance and electric charge on the interaction of VIVO species with proteins 100
Binding of VIV O2+ , VIV OL, VIV OL2 and VV O2 L Moieties to Proteins: X-ray/Theoretical Characterization and Biological Implications 93
Unveiling VIVO2+ Binding Modes to Human Serum Albumins by an Integrated Spectroscopic–Computational Approach 92
A Series of Non-Oxido VIVComplexes of Dibasic ONS Donor Ligands: Solution Stability, Chemical Transformations, Protein Interactions, and Antiproliferative Activity 90
Protein‐Protein Stabilization in VIVO/8‐Hydroxyquinoline–Lysozyme Adducts 88
Mo(VI) Potential Metallodrugs: Explaining the Transport and Cytotoxicity by Chemical Transformations 87
Quantitative prediction of electronic absorption spectra of copper(II)–bioligand systems: Validation and applications 87
Polyoxovanadates with emerging biomedical activities 85
Solution chemistry of oxidovanadium(IV) complexes with two bis-kojic acid derivatives 82
New VIV, VIVO, VVO, and VVO2Systems: Exploring their Interconversion in Solution, Protein Interactions, and Cytotoxicity 82
Binding of vanadium ions and complexes to proteins and enzymes in aqueous solution 80
Through-Space Spin Coupling in a Silver(II) Porphyrin Dimer upon Stepwise Oxidations: AgII⋅⋅⋅AgII, AgII⋅⋅⋅AgIII, and AgIII⋅⋅⋅AgIII Metallophilic Interactions 79
Interaction of VIVO–8-hydroxyquinoline species with RNase A: the effect of metal ligands in the protein adduct stabilization 75
Integrated experimental/computational approaches to characterize the systems formed by vanadium with proteins and enzymes 75
Implications of Protein Interaction in the Speciation of Potential VIVO-Pyridinone Drugs 72
Solution chemical properties and anticancer potential of 8-hydroxyquinoline hydrazones and their oxidovanadium(IV) complexes 70
Stepwise Oxidations in a Cofacial Copper(II) Porphyrin Dimer: Through-Space Spin-Coupling and Interplay between Metal and Radical Spins 70
Ferromagnetic Coupling in Oxidovanadium(IV)-Porphyrin Radical Dimers 69
Experimental and Computational Studies on the Interaction of DNA with Hesperetin Schiff Base CuII Complexes 69
Multiple and Variable Binding of Pharmacologically Active Bis(maltolato)oxidovanadium(IV) to Lysozyme 62
New mixed ligand oxidovanadium(IV) complexes: Solution behavior, protein interaction and cytotoxicity 60
Promising anticancer agents based on 8-hydroxyquinoline hydrazone copper(II) complexes 60
The binding modes of VIVO2+ions in blood proteins and enzymes 59
Polyoxidovanadates' interactions with proteins: An overview 59
Interaction with CT-DNA and in vitro cytotoxicity of two new copper(II)-based potential drugs derived from octanoic hydrazide ligands 57
Stabilization and Binding of [V4O12]4− and Unprecedented [V20O54(NO3)]n− to Lysozyme upon Loss of Ligands and Oxidation of the Potential Drug VIVO(acetylacetonato)2 47
Totale 2.730
Categoria #
all - tutte 11.882
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.882


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202152 0 0 0 0 0 2 18 6 13 13 0 0
2021/202297 4 0 0 0 9 1 2 9 10 8 7 47
2022/2023332 32 42 16 57 20 48 0 42 64 1 8 2
2023/202491 18 7 4 8 20 4 0 3 4 0 10 13
2024/20251.027 4 8 45 25 23 57 102 201 316 154 66 26
2025/20261.115 57 298 287 217 162 94 0 0 0 0 0 0
Totale 2.730